PBE Expert Français

Vaccines

A contained biotechnology production unit in Switzerland

For a biopharmaceutical company in Switzerland, PBE Expert delivered, on an EPCMV basis, the construction of a biotechnology pharmaceutical production unit (E. coli vaccine, BSL-2, sterile) with contained production areas.

  • FDA
  • EMA
An operator in a cleanroom in front of a sterile production machine

Project fact sheet

Client
Biopharmaceutical company
Location
Switzerland
Engagement
EPCMV
Facility
E. coli vaccine, BSL-2, sterile
Scale
CHF 59 million

Engagement : EPCMV

  1. EEngineeringEngineering
  2. PProcurementProcurement
  3. CConstructionConstruction
  4. MManagementManagement
  5. VValidationValidation

Project scale

  • 4,000 m² of ISO Class 7 and 8 production cleanrooms, with type 2 containment
  • 1,500 m² of technical areas
  • Electrical power: 2,000 kVA
  • Chilled water: 1,300 kW
  • Plant steam: two 5 t/h boilers
  • Clean steam: 1.2 t/h
  • Purified water: 2 m³/h
  • Compressed air: 600 Nm³/h
  • Total project cost: CHF 59 million

See also

Next project · Switzerland20,000 m² plantEngineering and construction management for an international pharmaceutical company’s new production plant in Switzerland, including its head office.

See alsoProjectsFormAction™

Let’s talk about your project.

A new site, an expansion, an inspection to prepare for: describe your project and one of our experts will get back to you.

Talk to an Expert